May 12, 2022 / 07:00PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Good afternoon, everybody. Welcome to the 2022 Bank of America Healthcare Conference and our final session. It's been a pleasure to see so many clients here after a 2-year hiatus, and it's great to see everybody there. Thank you for your support, just to start that up.
I'm Derik De Bruin, the Senior Life Sciences and Diagnostics Tools Analyst. And with us to close it out, and with us is Sam Samad, Chief Financial Officer. And thanks, Sam, for being here. Appreciate it and glad you could have accommodated us. I know your schedules were really difficult this year. So we certainly appreciate you coming out and helping us.
Questions and Answers:
Derik De Bruin - BofA Securities, Research Division - MD of Equity ResearchSo I'm a little bit perplexed. So you've put up record instrument placement numbers, right? I mean we've -- I think we've been just shocked at the number of systems that have been placed. And certainly, talking with investors -- certainly, earlier this year,
Trustpilot
